Genmab — November 2017
-
Mogan - gode news i dag vil være at ALCYONE præsentation kommer med på ASH som late breaker.
-
Gode news i morgen vil være stærke Darzalex salgstal fra Symphony Health. Helst 100 mio. USD i oktober.
-
Hvis ikke ALCYONE kommer med som late breaker, er der nok risiko for at markedet tolker data som ikke specielt stærke, og så er der langt til ASH!
-
Dette eksempel kunne bestyrelsesmedlemmerne i Genmab lære noget af https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=459944013&sourcecode=ddk
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind